医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

A Novel Lectin Was Isolated by the Research Team of Jinchi Biotech Ltd. (JBL)

2014年10月27日 PM05:00
このエントリーをはてなブックマークに追加


 

ZHANGJIAJIE, China

Lately, Andrias Davidianus Lectin (ADL) was isolated successfully from the body-surface mucus of Andrias Davidianus (Giant Salamander) by JBL Research Team who had done 3 years of research on purification of a secreted lectin from Andrias Davidianus skin and its antibacterial activity. In August of 2014, the research paper of ADL-related research achievement was published in ‘Comparative Biochemistry and Physiology, Part C, DOI: 10.1016/j.cbpc.2014.08.008’.

ADL is very important to the body-surface immunity of Andrias Davidianus. ADL is a 17 kDa carbohydrate-binding protein, and it contains 2 identical 8.5 kDa subunits. The discovery and application of the lectin have great significance for Andrias Davidianus breeding and disease prevention.

Lectins are considered to be non enzymatic and non immune proteins or multivalent carbohydrate-binding protein, widely exist in animals (including amphibians), plants and microorganisms. Isolation and identification of lectins are particularly important in the study on pathogenesis process of microbial related.

ABOUT JINCHI

www.jc-biotech.com

Owning the world’s only Giant Salamander Museum, Jinchi Biotech Ltd. mainly specialized in the R&D of giant salamander related biotech products with more than 40 skincare and health products under two product lines, namely SHINIQUE and ANDRIAS. With strong scientific research background and a comprehensive business model, Jinchi Biotech Ltd. values virtue and goodwill, commits to deliver quality products to consumers, and devotes to the health, beauty and biomedical industries.

Disclaimer

The statements contained herein are forward-looking statements that are subject to risks and uncertainties that could cause actual results to differ materially from those expressed in the forward-looking statements.

CONTACT

Jinchi Biotech Ltd.
Chan Luo, +86-731-8979-2661
ir@jc-biotech.com

Related Posts Plugin for WordPress, Blogger...

同じカテゴリーの記事 

  • Medidata宣布快速扩展其传感器云网络,再添10家卫生技术创新组织
  • ウォルグリーン・ブーツ・アライアンスが戦略的見直しを完了し、好業績のブーツ事業の所有権を保持することを決定
  • OliX Pharmaceuticals Announces IND Submission to U.S. FDA to Evaluate Safety and Tolerability of OLX10212 in Phase 1 Clinical Trial
  • DEXLEVO Strengthens Global Reputation of GOURI at IMCAS, the World’s Largest Beauty Anti-Aging Society
  • Sensorion Announces Approval in Australia to Initiate Proof of Concept Clinical Trial of SENS-401 for Residual Hearing Preservation During Cochlear Implantation